| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis
|
Tarantini, L.
|
|
|
23 |
12 |
p. 3058-3063
|
artikel
|
| 2 |
A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation
|
van Riel, S.
|
|
|
23 |
12 |
p. 3188-3189
|
artikel
|
| 3 |
Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study
|
Alba, E.
|
|
|
23 |
12 |
p. 3069-3074
|
artikel
|
| 4 |
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid†
|
Vadhan-Raj, S.
|
|
|
23 |
12 |
p. 3045-3051
|
artikel
|
| 5 |
Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy
|
Tominaga, N.
|
|
|
23 |
12 |
p. 3051-3057
|
artikel
|
| 6 |
Dietary patterns and upper aerodigestive tract cancers: an overview and review
|
Bravi, F.
|
|
|
23 |
12 |
p. 3024-3039
|
artikel
|
| 7 |
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study
|
de Leval, L.
|
|
|
23 |
12 |
p. 3143-3151
|
artikel
|
| 8 |
Editorial board
|
|
|
|
23 |
12 |
p. ii-iii
|
artikel
|
| 9 |
HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?
|
Hompes, D.
|
|
|
23 |
12 |
p. 3123-3129
|
artikel
|
| 10 |
Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib‡
|
George, S.
|
|
|
23 |
12 |
p. 3180-3187
|
artikel
|
| 11 |
Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study
|
Nederend, J.
|
|
|
23 |
12 |
p. 3098-3103
|
artikel
|
| 12 |
International models of investigator-initiated trials: implications for Japan
|
Trimble, E.L.
|
|
|
23 |
12 |
p. 3151-3155
|
artikel
|
| 13 |
Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature
|
Cardonick, E.
|
|
|
23 |
12 |
p. 3016-3023
|
artikel
|
| 14 |
Meat consumption and risk of lung cancer: evidence from observational studies
|
Yang, W.S.
|
|
|
23 |
12 |
p. 3163-3170
|
artikel
|
| 15 |
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement†
|
Guiu, S.
|
|
|
23 |
12 |
p. 2997-3006
|
artikel
|
| 16 |
Multifocality and multicentricity in breast cancer and survival outcomes
|
Lynch, S.P.
|
|
|
23 |
12 |
p. 3063-3069
|
artikel
|
| 17 |
Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer
|
Mohd Sharial, M.S.N.
|
|
|
23 |
12 |
p. 3007-3016
|
artikel
|
| 18 |
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
|
Argyriou, A.A.
|
|
|
23 |
12 |
p. 3116-3122
|
artikel
|
| 19 |
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
|
Ruddy, K.J.
|
|
|
23 |
12 |
p. 3075-3081
|
artikel
|
| 20 |
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer
|
Verschraegen, C.F.
|
|
|
23 |
12 |
p. 3104-3110
|
artikel
|
| 21 |
Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas
|
Mimae, T.
|
|
|
23 |
12 |
p. 3129-3137
|
artikel
|
| 22 |
Public health oncology: a framework for progress in low- and middle-income countries†
|
Love, R.R.
|
|
|
23 |
12 |
p. 3040-3045
|
artikel
|
| 23 |
Putting public health back into the global cancer agenda
|
Sullivan, R.
|
|
|
23 |
12 |
p. 2995-2996
|
artikel
|
| 24 |
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients
|
Fontein, D.B.Y.
|
|
|
23 |
12 |
p. 3091-3097
|
artikel
|
| 25 |
Risk of treatment-related esophageal cancer among breast cancer survivors
|
Morton, L.M.
|
|
|
23 |
12 |
p. 3081-3091
|
artikel
|
| 26 |
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis
|
Giacchetti, S.
|
|
|
23 |
12 |
p. 3110-3116
|
artikel
|
| 27 |
Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study
|
Poprach, A.
|
|
|
23 |
12 |
p. 3137-3143
|
artikel
|
| 28 |
Sunitinib malate in solitary fibrous tumor (SFT)
|
Stacchiotti, S.
|
|
|
23 |
12 |
p. 3171-3179
|
artikel
|
| 29 |
Table of Contents
|
|
|
|
23 |
12 |
p. iv-v
|
artikel
|
| 30 |
The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends
|
Thrift, A.P.
|
|
|
23 |
12 |
p. 3155-3162
|
artikel
|
Tijdschrift beschrijving